Mainz Biomed (MYNZ) Receivables (2020 - 2025)
Historic Receivables for Mainz Biomed (MYNZ) over the last 6 years, with Q2 2025 value amounting to $24411.0.
- Mainz Biomed's Receivables rose 13758.49% to $24411.0 in Q2 2025 from the same period last year, while for Jun 2025 it was $24411.0, marking a year-over-year increase of 13758.49%. This contributed to the annual value of $50815.0 for FY2024, which is 5825.77% down from last year.
- As of Q2 2025, Mainz Biomed's Receivables stood at $24411.0, which was up 13758.49% from $50815.0 recorded in Q4 2024.
- Mainz Biomed's Receivables' 5-year high stood at $121735.0 during Q4 2023, with a 5-year trough of -$148110.0 in Q3 2022.
- Its 5-year average for Receivables is $1436.4, with a median of $24411.0 in 2025.
- As far as peak fluctuations go, Mainz Biomed's Receivables soared by 15280.17% in 2021, and later crashed by 5825.77% in 2024.
- Quarter analysis of 5 years shows Mainz Biomed's Receivables stood at $111842.0 in 2021, then crashed by 232.43% to -$148110.0 in 2022, then soared by 182.19% to $121735.0 in 2023, then crashed by 58.26% to $50815.0 in 2024, then tumbled by 51.96% to $24411.0 in 2025.
- Its Receivables was $24411.0 in Q2 2025, compared to $50815.0 in Q4 2024 and -$64949.0 in Q2 2024.